Insider Transactions in Q1 2023 at Integra Lifesciences Holdings Corp (IART)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2023
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Payment of exercise price or tax liability
|
Direct |
1,469
-1.56%
|
$76,388
$52.61 P/Share
|
|
Mar 13
2023
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
204
-0.81%
|
$10,608
$52.61 P/Share
|
|
Mar 13
2023
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,331
-1.42%
|
$75,867
$57.61 P/Share
|
|
Mar 13
2023
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
953
-1.1%
|
$49,556
$52.61 P/Share
|
|
Mar 13
2023
|
Lisa Evoli EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
959
-2.5%
|
$49,868
$52.61 P/Share
|
|
Mar 12
2023
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Payment of exercise price or tax liability
|
Direct |
1,637
-1.13%
|
$85,124
$52.87 P/Share
|
|
Mar 12
2023
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-0.76%
|
$15,132
$52.87 P/Share
|
|
Mar 12
2023
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,170
-0.81%
|
$60,840
$52.87 P/Share
|
|
Mar 12
2023
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,629
-1.22%
|
$84,708
$52.87 P/Share
|
|
Mar 12
2023
|
Lisa Evoli EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
972
-1.62%
|
$50,544
$52.87 P/Share
|
|
Mar 11
2023
|
Jan De Witte President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,842
-43.42%
|
$199,784
$52.87 P/Share
|
|
Mar 11
2023
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Payment of exercise price or tax liability
|
Direct |
1,257
-1.26%
|
$65,364
$52.87 P/Share
|
|
Mar 11
2023
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
243
-0.93%
|
$12,636
$52.87 P/Share
|
|
Mar 11
2023
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
3,764
-3.67%
|
$195,728
$52.87 P/Share
|
|
Mar 11
2023
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,348
-1.46%
|
$70,096
$52.87 P/Share
|
|
Mar 11
2023
|
Lisa Evoli EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
760
-1.81%
|
$39,520
$52.87 P/Share
|
|
Mar 10
2023
|
Robert T. Davis Jr. EVP & President, TT |
BUY
Grant, award, or other acquisition
|
Direct |
4,227
+7.77%
|
-
|
|
Mar 10
2023
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+11.01%
|
-
|
|
Mar 10
2023
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
5,070
+8.85%
|
-
|
|
Mar 10
2023
|
Michael J. Mc Breen EVP & President, CSS |
BUY
Grant, award, or other acquisition
|
Direct |
17,586
+17.37%
|
-
|
|
Mar 10
2023
|
Lisa Evoli EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
2,532
+10.7%
|
-
|
|
Mar 07
2023
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Open market or private sale
|
Direct |
1,843
-6.02%
|
$99,522
$54.29 P/Share
|
|
Mar 02
2023
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
723
-2.31%
|
$39,765
$55.09 P/Share
|
|
Mar 01
2023
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Open market or private sale
|
Direct |
1,566
-3.3%
|
$86,130
$55.21 P/Share
|
|
Mar 01
2023
|
Robert T. Davis Jr. EVP & President, TT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,566
+3.19%
|
$40,716
$26.86 P/Share
|
|
Feb 27
2023
|
Lisa Evoli EVP & CHRO |
SELL
Open market or private sale
|
Direct |
3,767
-16.84%
|
$214,719
$57.0 P/Share
|
|
Feb 13
2023
|
Jan De Witte President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,848
+50.0%
|
-
|
|
Feb 13
2023
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
9,757
+5.12%
|
-
|
|
Feb 13
2023
|
Robert T. Davis Jr. EVP & President, TT |
BUY
Grant, award, or other acquisition
|
Direct |
7,108
+3.94%
|
-
|
|
Feb 13
2023
|
Michael J. Mc Breen EVP & President, CSS |
BUY
Grant, award, or other acquisition
|
Direct |
6,073
+4.97%
|
-
|
|
Feb 13
2023
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,537
+3.87%
|
-
|
|
Feb 13
2023
|
Lisa Evoli EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
4,375
+4.99%
|
-
|
|
Jan 18
2023
|
Jan De Witte President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
431
-100.0%
|
$23,274
$54.78 P/Share
|
|
Jan 18
2023
|
Jan De Witte President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
431
+50.0%
|
-
|